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Microbiological Factors In¯uencing the Outcome of Nosocomial Bloodstream
Infections: A 6-Year Validated, Population-Based Model
Didier Pittet, Ning Li, Robert F. Woolson, From the Division of General Medicine, Clinical Epidemiology and
Health Services Research, and the Division of Biostatistics, Departmentand Richard P. Wenzel
of Preventive Medicine and Environmental Health, University of Iowa
College of Medicine, Iowa City, Iowa
All patients (n 1,745) with nosocomial bloodstream infection identified between 1986 and 1991 at
a single 900-bed tertiary care hospital were studied to identify microbiological factors independently
associated with mortality due to the infection. Patients were identified by prospective, case-based
surveillance and positive blood cultures. Mortality rates were examined for secular trends. Prognostic
factors were determined with use of univariate and multivariate analyses, and both derivation and
validation sets were used. A total of 1,745 patients developed nosocomial bloodstream infection. The
28-day crude mortality was 22%, and crude in-hospital mortality was 35%. Factors independently (all
P  .05) associated with increased 28-day mortality rates were older age, longer length of hospital
stay before bloodstream infection, and a diagnosis of cancer or disease of the digestive system.
After adjustment for major confounders, Candida species were the only organisms independently
influencing the outcome of nosocomial bloodstream infection (odds ratio [OR] for mortality  1.84;
95% confidence interval [CI], 1.22–2.76; P  .0035). The two additional microbiological factors
independently associated with increased mortality were pneumonia as a source of secondary infection
(OR  2.74; 95% CI, 1.87–4.00; P  .0001) and polymicrobial infection (OR  1.68; 95% CI,
1.22–2.32; P  .0014). Our data suggest that microbiological factors independently affect the out-
come of nosocomial bloodstream infection.
Each year, about 250,000 of the 35 million patients admitted infection after the underlying disease is controlled for. In six
speci®cally designed studies, the attributable mortality due toto hospitals in the United States develop nosocomial blood-
stream infections. According to vital statistics reports, the age- nosocomial bloodstream infection averaged 26% [10] but var-
ied with the organism causing the infection. For example, theadjusted death rate due to septicemia has shown a linear in-
crease over the past 4 decades [1]. Mortality rates associated attributable mortality associated with coagulase-negative staphy-
lococci (CNS) was 14%; with Candida species, 38%; and withwith nosocomial bloodstream infections are higher than those
associated with community-acquired infections [2±4]. In the enterococci, 31%. We recently reported the attributable mor-
tality of nosocomial bloodstream infections in critically ill sur-largest community-based study published so far [4], 51% of
the 2,978 episodes of bacteremia documented were hospital- gical patients to be 35% (95% CI, 25%±45%) [11].
The primary objective of the study reported herein was toacquired, and those were associated with a 50% higher risk of
death than were community-acquired infections. Other studies examine the importance of microbiological factors in the out-
come of nosocomial bloodstream infection. We accounted forhave con®rmed this observation [2, 3, 5±8].
The crude mortality associated with bloodstream infection many important confounders and examined the secular trends
in mortality rates.approximates 35%, ranging from 12% to 80% [2±4, 6, 9]. The
attributable mortality de®nes the mortality directly due to the
Methods
Hospital Setting
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The University of Iowa Hospitals and Clinics (UIHC) is aPresented in part at the 6th Annual Meeting of the Society for Healthcare
Epidemiology of America, held in Washington, D.C., 21±23 April 1996. 902-bed institution serving Iowa and the bordering areas of
Present addresses: Dr. N. Li, Health Study Group, Westat Inc., 1650 Re- surrounding states. The UIHC is a tertiary health care centersearch Blvd, Rockville, Maryland 20850; Dr. R. P. Wenzel, Department of
admitting 22,000 patients per year. During the study period,Internal Medicine, Medical College of Virginia, Virginia Commonwealth Uni-
versity, Sanger Hall, Room 7015, 1101 East Marshall Street, Richmond, Vir- a maximum of 220 beds were designated for intensive care [12].
ginia 23298. Continual prospective surveillance for nosocomial infectionsReprints or correspondence (current address): Dr. Didier Pittet, Infection
began in 1976, and recent studies using standard methods haveControl Program, Division of Infectious Diseases, Department of Internal Med-
icine, HoÃpital Cantonal Universitaire de GeneÁve, 24 rue Micheli-du-Crest, 1211 estimated the sensitivity and speci®city of this hospital-wide
Geneva 14, Switzerland. reporting of nosocomial infection to be 81% and 97%, respec-
Clinical Infectious Diseases 1997;24:1068±78 tively [13]. This surveillance system is case-based and utilizes
q 1997 by The University of Chicago. All rights reserved.
1058±4838/97/2406±0005$02.00 clinically important criteria: all patients identi®ed had received
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systemic antibiotic therapy directed at the organisms isolated According to the de®nitions proposed by the CDC, primary
bloodstream infections include those resulting from intravenousin blood cultures.
or arterial line infections [14]. For descriptive and analytic
purposes, however, the latter were strati®ed separately as pre-Study Objective and Methods
viously de®ned [11, 12]. In brief, only microbiologically docu-
The primary objective of the study was to determine the
mented (by the semiquantitative culture technique described by
importance of microbiological factors per se for in¯uencing
Maki et al. [15]) line infections were subclassi®ed as catheter-
mortality following nosocomial bloodstream infections.
related bloodstream infections. Thus, infections that occurred
All patients admitted to the UIHC who developed a nosoco-
in the presence of an intravascular catheter but without docu-
mial bloodstream infection between 1 July 1986 and 30 June
mentation of line infection by positive semiquantitative tip cul-
1991 were included in the study. The UIHC's de®nition of
ture [15] were classi®ed as primary bloodstream infection.
nosocomial bloodstream infection was based on that of the
Secondary bloodstream infection was de®ned by infection
Centers for Disease Control and Prevention (CDC) [12, 14]
that developed subsequent to a documented infection with the
and required one (unless the organism was judged to be a
same microorganism at another body site [14]. Polymicrobial
contaminant) or more positive cultures of blood drawn at least
bloodstream infection refers to infections in which more than
72 hours after admission, in association with clinical signs of
one microorganism was recovered from the blood within a 48-
sepsis (based on standard de®nitions [12, 14]).
hour window after another had been isolated [16, 17].
In cases in which the organisms could potentially be skin
Sources of secondary bloodstream infection included the fol-
contaminants (e.g., Bacillus species, CNS, diphtheroids, micro-
lowing: lower respiratory tract infections, urinary tract infec-
cocci, or Propionibacterium species), the de®nition of blood-
tions, surgical wound infections, infections of gastrointestinal
stream infection required all of the following: (1) two or more
origin, intravenous or arterial line±related infections, and
positive cultures of blood drawn at least 72 hours after admis-
others (eye infections [n  2]; skin infections [n  27]; upper
sion or at least one positive culture of blood from a patient
respiratory tract infections [n  21]; oropharyngeal infections
with an intravascular line; (2) the presence of at least one of
[n  8]; and infections of gynecologic origin [n  21]).
the following: temperature of 387C, hypothermia (367C),
A diagnosis of nosocomial pneumonia required the ®nding
chills, or hypotension (systolic blood pressure, 90 mm Hg);
on chest radiographic examination of a new or progressive
and (3) initiation of appropriate antimicrobial therapy.
in®ltrate, consolidation, cavitation, or pleural effusion and at
Thus, all patients in the study presented clinical signs of
least one of the following [14]: (1) new onset of purulent
sepsis associated with laboratory-proven bloodstream infec-
sputum or change in the character of sputum, (2) organism(s)
tion; in cases of potential skin contaminants, the infections
cultured from blood, (3) isolation of an etiologic agent from a
were considered clinically important and were treated by the
specimen obtained by transtracheal aspiration, bronchial brush-
physician.
ing, bronchoalveolar lavage, or biopsy, or (4) histopathologic
Bloodstream infection and corresponding crude mortality
evidence of pneumonia. De®nitions for other sources of infec-
rates were calculated for the following pathogens: CNS, Sta-
tion referred to recognized standards [14].
phylococcus aureus, streptococci, enterococci, Escherichia
All patients who entered the operating unit were recorded
coli, Klebsiella species; Enterobacter species, Pseudomonas
as having had surgery. Only patients hospitalized for at least
aeruginosa, Serratia marcescens, Candida species; and others.
24 hours in intensive care units (ICUs) before the occurrence
Other analyses also included organisms considered as larger
of bloodstream infection were considered to have been exposed
groups: gram-positive cocci, aerobic gram-negative bacilli,
to a critical care unit. Neutropenia was de®ned as a total peri-
fungi, and others.
pheral WBC count 1,000/mm3 or a polymorphonuclear neu-
The primary outcome measure examined was 28-day mortal-
trophil count500/mm3 prior to the occurrence of bloodstream
ity. In the event that the same patient had more than one episode
infection.
of bloodstream infection, only the ®rst episode was considered
Underlying medical or surgical conditions were classi®ed
in the analysis of mortality, except when death occurred 28
according to the primary diagnosis at admission and on the
days after bloodstream infection. In the latter situation, death
basis of the International Classi®cation of Diseases, Ninth
due to the subsequent episode was considered [12]. We ex-
Revision, Clinical Modi®cation (ICD-9-CM) codes [18]. There
cluded from the analysis of mortality patients whose blood
were 20 separate groups of diagnoses.
cultures were performed post-mortem. Total in-hospital mor-
tality, regardless of length of stay, was used as a secondary
Changes over Study Periodoutcome measure for descriptive purposes.
As previously described [12], the following changes that
De®nitions occurred over the study period were examined: average length
of stay, surveillance activities, de®nitions of nosocomial infec-Primary bloodstream infection refers to bacteremia (or
fungemia) for which there was no documented distal source. tion, and microbiological laboratory techniques. Between 1986
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and 1991 the average length of stay remained stable for acute Results
inpatients; the length of stay averaged 8.27 { 0.16 days
Between 1986 and 1991, 120,841 patients were admitted to(median, 7 days; range, 7.98±8.48 days). Neither surveillance
UIHC, averaging 21,140 patients a year and representing aactivities nor de®nitions of nosocomial bloodstream infection
total of 999,355 patient-days of care. Over the 6-year studychanged during the study period.
period, a total of 1,745 patients were prospectively identi®edBetween 1 January 1986 and 1 October 1987 the BACTEC
with clinically important, nosocomial bloodstream infections460 radiometric system (Johnston Laboratories, Towson, MD)
(1.44 per 1,000 discharges). Secular trends in bloodstream in-was used, and a 5-mL blood culture inoculum was standard.
fection rates at UIHC and associated crude mortality rates haveAfter 1 October 1987 the BACTEC 660 nonradiometric system
recently been described for the period 1980±1992 [12].was used. After 1 April 1988 the standard blood culture inocu-
lum doubled from 5 mL to 10 mL. It is estimated that an
enhanced recovery of 33% occurred with use of the 10-mL Study Population and Characteristics of Patients
inoculum and nonradiometric system [19].
The mean age of the study population was 49 years (median,
45 years). There were 995 males (57%) and 750 females (43%).
A total of 534 patients (30%) had surgery, and 659 patients
Statistical Analysis (38%) were admitted to an ICU prior to onset of bloodstream
infection. A total of 366 patients (21%) had documented neu-
Trends in nosocomial bloodstream infection and mortality tropenia before infection occurred. Sex, prior surgery, admis-
rates between 1980 and 1992 have recently been described in sion to an ICU, and documented neutropenia were not associ-
detail [12]. Factors associated with mortality due to blood- ated with an increased risk of death within 28 days following
stream infection were initially analyzed by univariate analysis. bloodstream infection (table 1).
The strength of the association between single prognostic vari- The median length of hospital stay from admission to blood-
ables and outcome (28-day or in-hospital mortality), odds ratios stream infection was 12 days; it did not vary during the study
(ORs), and their corresponding 95% con®dence intervals (95% period. The longer the patients stayed in the hospital before
CIs) were calculated. For continuous variables, mean values developing the infection, the poorer the outcome. A third of the
were compared with two sample t-tests for independent samples study cohort (520 of 1,745) developed nosocomial bloodstream
after correction for equality of variance (F test). Differences infection within 7 days following admission to the hospital;
in proportions were compared with either the x2 test or Fisher's among those patients the 28-day and in-hospital mortality rates
exact test (for expected cell frequencies less than ®ve). were 17% and 26%, respectively (table 1). Among patients
Independent prognostic variables were de®ned by multi- who acquired the infection14 days after admission (n 703;
variate logistic regression analysis. The 14 variables recorded 40%), 28-day and in-hospital mortality rates were signi®cantly
at baseline for each individual in the analysis were as follows: higher: 27% and 44%, respectively (x2 test for trends and
age; admission to ICU before the time of bloodstream infection P values for 28-day and in-hospital mortality: x2  22.8 and
(yes or no); length of stay from admission to infection; neutro- 48.2, respectively; all P values .0001).
penia (yes or no); a diagnosis of cancer or disease of the diges- Patients were admitted to the hospital for a variety of medical
tive tract (yes or no); the year in which the infection occurred or surgical conditions. To account for the effect of underlying
(1986, 1987, 1988, 1989, 1990, or 1991); and microbiological disease in the analysis, we strati®ed patients according to the
variables (primary infection; pneumonia; infections caused by primary diagnosis for admission (table 2). Cancer and diseases
gram-negative organisms, P. aeruginosa, CNS, or Candida of the digestive system were the only underlying conditions
species; bacteremic episodes lasting ⁄72 hours; and poly- associated with an increased risk of death within 28 days fol-
microbial infection). lowing bloodstream infection. A total of 524 patients (30%)
Microbiological variables were coded as yes or no. The two had cancer. Both 28-day (25%) and in-hospital (40%) mortality
outcomes of interest were the 28-day and the total in-hospital rates following infection were signi®cantly higher among can-
mortality. In addition, whether the patient developed multiple cer patients than among patients suffering from other medical
episodes of bloodstream infection during the same hospital conditions.
stay was tested when in-hospital mortality was the outcome The odds ratio for death within 28 days following onset of
measure. The model was built by the logistic regression proce- infection in patients with cancer vs. that for patients without
dure with SAS version 6.0 (SAS Institute, Cary, NC), with an cancer was 1.31 (95% CI, 1.03±1.67; P  .004; table 2).
entrance P value of £.15 for inclusion. For descriptive pur- Similarly, among 154 patients suffering from diseases of the
poses, independent variables associated with poor outcome digestive system, both 28-day (29%) and total in-hospital
were also identi®ed, with use of 14-day as well as 21-day (44%) mortality rates were signi®cantly higher (P  .015) than
mortality as outcome measures. All tests were two-tailed, and in the study population (table 2). Primary diagnosis groups
associated with trends toward lower risk of death in the 28P values .05 were considered signi®cant.
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Table 1. Characteristics associated with death within 28 days due to nosocomial bloodstream infection in patients at the University of Iowa
Hospitals and Clinics, 1986±1991: univariate analysis.
No. of patients
Survivors Nonsurvivors 28-d Mortality
Characteristic (n  1,364) (n  381) (%) OR 95% CI
Age (mean, y) 43 56 . . . 1.017 1.012±1.021
Male 777 (57%) 218 (57%) 22 1.01 0.80±1.27
Female 587 (43%) 163 (43%) 22 . . . . . .
Underwent surgery* 421 113 21 0.94 0.74±1.21
Admitted to ICU* 510 149 22 1.08 0.85±1.36
Neutropenic*² 280 86 23 1.13 0.86±1.48
Length of stay (d)*³
1±7 433 87 17 1.006 1.003±1.011
8±14 421 101 19 . . . . . .
⁄15 510 193 27 . . . . . .
NOTE. ICU  intensive care unit.
* Before the occurrence of bloodstream infection was considered.
² WBC count 1,000/mm3 or polymorphonuclear neutrophil count 500/mm3.
³ Exposure odds ratio for death assessed by univariate logistic regression (constant  0.199; P  .036).
days following the onset of infection included complications of 1,561 [28%] and 291 of 1,561 [19%], respectively). Al-
though 28-day mortality rates were similar among the twoof pregnancy (50 episodes, no deaths), liveborn infants (61
episodes, 8 deaths), and conditions originating in the perinatal groups of patients (16% and 22%, respectively), in-hospital
deaths were more frequent among those with multiple episodesperiod (26 episodes, no deaths) (table 2).
of infection (95 of 184 [52%] vs. 515 of 1,561 [33%], respec-
tively; OR for in-hospital death  2.17; 95% CI, 1.58±2.98;
Crude 28-Day and In-Hospital Mortality Rates
P  .001).
Among 1,745 patients with bloodstream infection, 610 died;
the crude in-hospital mortality was 35%. The 28-day crude
Source of Bloodstream Infections
mortality was 22% (381 of 1,745). The crude in-hospital mor-
tality among patients with nosocomial bloodstream infections There were 1,090 episodes of primary bloodstream infections
(1,090 of 1,745  62%). Among those, 212 infections (19%)decreased signi®cantly from 43% in 1986 to 27% in 1991
(r  0.90; P  .014). Similarly, the 28-day mortality rates were associated with a previous intravenous or arterial line±
related infection (table 3). A large majority (157; 74%) ofshowed a trend toward a signi®cant decrease, declining from
26% in 1986 to 16% in 1991 (r  0.82; P  .047). line-related bloodstream infections (proven by semiquantitative
cultures) were caused by staphylococci (S. aureus, n  79; andIn an attempt to analyze reasons for the secular trend toward
decreasing 28-day mortality (P  .047), we examined possible CNS, n  78). Line-associated bloodstream infections devel-
oped an average of 15.6 days following admission; almost halfin¯uences of infecting organisms. In fact, the increasing inci-
dence of CNS had a profound in¯uence on rates: after correc- (101 of 212; 48%) of the infections developed in patients who
remained in or had been discharged from ICUs. A third (60)tion for the confounding variable (infections caused by CNS),
the initially observed signi®cant trend diseappeared (P  .42). of these 212 patients had cancer or diseases of the digestive
tract, and 16 (7.5%) had a subsequent episode of bloodstreamA total of 184 patients (10.5%) had multiple episodes of
nosocomial bloodstream infection during their stay in the hos- infection during their hospital stay. Crude 28-day and in-hospi-
tal mortality rates among patients with CNS (17% and 28%,pital; 23 (12%) had 2 episodes (range, 2±4 episodes). Pa-
tients with multiple episodes of infection did not differ from respectively) and S. aureus (15% and 23%, respectively) line-
associated bloodstream infections were comparable.those with a single episode of infection (n  1,561) in terms
of age (mean age, 43 y vs. 42 y), gender (59% vs. 57% were A total of 655 bloodstream episodes were secondary to a
previously documented nosocomial infection (655 of 1,745;male), prior exposure to surgery (30% vs. 31%), or admission
to the ICU (37% vs. 38%). 38%). Secondary bloodstream infections were associated with
higher 28-day mortality (187 of 655; 29%) and in-hospitalThe proportions of patients with cancer (85 of 184; 46%)
and neutropenia (76 of 184; 41%) were signi®cantly (P  .05) mortality (283 of 655; 43%) than were primary infections (194
of 1,090 [18%] and 327 of 1,090 [30%], respectively). Thehigher among patients who had multiple episodes than among
those who had a single episode of bloodstream infection (439 odds ratio for death within 28 days following infection for
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Table 2. Primary diagnoses for admission and mortality rates associated with nosocomial bloodstream infection in patients at the University
of Iowa Hospitals and Clinics, 1986±1991.
No. of patients
28-d Mortality
Primary diagnosis group ICD-9-CM codes [18] Survivors Nonsurvivors (%) OR* 95% CI
1: Infectious diseases 001±139 47 12 20 0.91 0.48±1.74
2: Neoplasms 140±239 392 132 25 1.31² 1.03±1.67
3: Endocrine disorders 240±279 30 8 21 0.95 0.43±2.10
4: Diseases of the blood 280±289 27 11 29 1.47 0.72±3.00
5: Mental disorders 290±319 3 1 25 1.19 0.12±11.5
6: Diseases of the nervous system 320±389 21 4 16 0.68 0.23±1.99
7: Diseases of the circulatory system 390±459 207 64 24 1.13 0.83±1.53
8: Diseases of the respiratory system 460±519 30 11 27 1.32 0.66±2.66
9: Diseases of the digestive system 520±579 110 44 29 1.49² 1.03±2.15
10: Diseases of the genitourinary system 580±629 48 13 21 0.97 0.52±1.81
11: Complications of pregnancy,
childbirth, or puerperium 630±679 50 0 0 . . . . . .
12: Skin and subcutaneous tissue diseases 680±709 6 4 40 2.40 0.67±8.55
13: Musculoskeletal system diseases 710±739 22 3 12 0.48 0.14±1.63
14: Congenital anomalies 740±759 32 6 16 0.67 0.28±1.60
15: Conditions originating in the perinatal
period 760±779 26 0 0 . . . . . .
16: Aspeci®c symptoms 780±799 21 6 22 1.02 0.41±2.55
17: Traumas or burns 800±989 130 29 18 0.78 0.51±1.19
18: Graft/surgery complications 990±999 62 19 23 1.10 0.65±1.87
19: Others (NEC) V10±V29/V40±V80 47 6 11 0.45 0.19±1.06
20: Live-born infants V30±V39 53 8 13 0.53 0.25±1.16
Total . . . 1,364 381 22 . . . . . .
NOTE. NEC  not elsewhere classi®ed (ICD-9-CM codes V10±29 and V40±V80).
* The odds ratios (and 95% CIs) for developing a bloodstream infection were calculated for each primary diagnosis group (1±20) with use of all other diagnosis
groups as baseline.
² For P values .05.
patients with secondary bloodstream infection was 1.85 (95% Polymicrobial infections accounted for 14% (247) of the epi-
sodes.CI, 1.47±2.32; P  .001). Polymicrobial infections had a
poorer outcome, as re¯ected in higher crude 28-day mortality Gram-positive cocci were the organisms most commonly
responsible for nosocomial bloodstream infection in the study(75 of 247 [30%]; OR  1.70; 95% CI, 1.26±2.29; P  .001)
and in-hospital mortality (116 of 247 [47%]; OR  1.83; 95% period; they were isolated from 55% (952) of the 1,745 infec-
tions. They were associated with lower 28-day mortality (18%)CI, 1.40±2.41; P  .001).
By univariate analysis, pneumonia as a source of secondary and in-hospital mortality (30%) than were aerobic gram-nega-
tive rods (24% and 37%, respectively). Fungal infections werebloodstream infection was signi®cantly associated with a
poorer outcome, in comparison with the other sources (table 3). associated with signi®cantly higher 28-day mortality (35%)
and in-hospital mortality (57%) than were infections due toBoth 28-day and in-hospital mortality following bloodstream
infection episodes that complicated nosocomial pneumonia other organisms; the odds ratio for death within 28 days due
to fungemia was 2.07 (95% CI, 1.41±3.04; P  .001), inwere associated with signi®cantly higher exposure odds ratios
for death (OR  3.28; 95% CI, 2.39±4.45; P  .001; and OR comparison with that for bloodstream infections caused by
other organisms. 3.56; 95% CI, 2.61±4.86; P  .001, respectively) than
were those for infections of other origins. Among primary The 10 leading pathogens isolated in episodes of nosocomial
bloodstream infection at UIHC from 1986 through 1991 arebloodstream infections, line-related infections were associated
with a signi®cantly lower risk for death in the study population listed in table 4; 28-day as well as in-hospital mortality and
estimated exposure odds ratios for death (28 days after infec-(OR  0.58; 95% CI, 0.39±0.86; P  .009).
tion) are shown in parallel. CNS were the most frequently
isolated pathogens, involved in 25% of all episodes of blood-
Bloodstream Isolates and Pathogen-Speci®c Mortality Rates
stream infection; they were associated with signi®cantly lower
28-day mortality rates than were other organisms (OR  0.63;A total of 2,046 isolates were recovered in 1,745 episodes
of nosocomial bloodstream infection over the study period. 95% CI, 0.48±0.82; P  .004) (table 4).
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Table 3. Sources of infection and associated mortality rates for 1,745 episodes of nosocomial bloodstream infection.
No. (%) In-hospital
of Percentage of 28-d Mortality mortality In-hospital:28-d
Type, source of infection episodes total episodes (%) OR 95% CI P value (%) mortality ratio
Primary bloodstream infection 1,090 62 18 . . . . . . . . . 30 1.69
Previous line-related
infection² 212 (19) . . . 15 0.58 0.39±0.86 .009 25 1.71
Secondary bloodstream infection 655 38 29 . . . . . . . . . 43 1.51
Pneumonia 193 (29) . . . 44 3.28 2.39±4.45 .001 69 1.59
Surgical wound 177 (27) . . . 24 1.17 0.81±1.68 .46 33 1.36
Urinary tract infection³ 127 (19) . . . 18 . . . . . . . . . 44 2.44
Gastrointestinal tract 27 (4) . . . 22 1.02 0.41±2.55 .86 44 1.98
Other§ 131 (20) . . . 24 1.17 0.77±1.78 .52 37 1.52
NOTE. Only the leading sources of infections are listed; the odds ratios and 95% CIs for mortality were calculated for each leading source of infection with
use of all other sources as baseline.
² Only microbiologically documented line-related infections were separated from the total number of primary bloodstream infections.
³ 109 of 127 (86%) were associated with the use of a urinary catheter.
§ Includes infections at other sites (e.g., gynecologic tract, upper respiratory tract, eye, brain).
S. aureus was the second most important pathogen. Candida derived from data regarding patients admitted in ®scal years
1986, 1987, 1988, 1989, and 1990 and were prospectivelyspecies were isolated in 134 infectious episodes and were the
fourth leading pathogens responsible for bloodstream infection validated with data for patients admitted in 1991.
The analysis indicated that the best predictor of 28-day mor-in the study period. By univariate analysis, Candida species
and P. aeruginosa were associated with signi®cantly higher tality in the study population was a model composed of six
of the 14 variables tested (table 5); these included age28-day mortality rates than were other organisms (OR  1.98;
95% CI, 1.36±2.88; P  .0002; and OR  1.58; 95% CI, (OR  1.018 per year; 95% CI, 1.014±1.02; P  .0001),
primary diagnosis of cancer or disease of the digestive tract1.02±2.43; P  .024, respectively).
(OR  1.60; 95% CI, 1.23±2.08; P  .0004), and increased
duration of hospital stay at the time of infection (OR  1.009
Independent Prognostic Factors
per day in the hospital; 95% CI, 1.003±1.02; P  .002).
Microbiological factors that independently in¯uenced theFactors independently in¯uencing 28-day as well as in-hos-
pital mortality due to nosocomial bloodstream infection were outcome were pneumonia as a source of secondary bloodstream
infection (OR  2.74; 95% CI, 1.87±4.00; P  .0001), infec-derived from multiple logistic regression procedures. The study
population was divided into a derivation set and a validation tions due to Candida species (OR  1.84; 95% CI, 1.22±2.76;
P  .0035), and polymicrobial infections (OR  1.68; 95% CI,set in order to assess speci®city and sensitivity as well as
consistency of the models derived. The models presented were 1.22±2.32; P  .0014). Although not statistically signi®cant in
Table 4. Pathogens most commonly responsible in 1,745 episodes of nosocomial bloodstream infection, as related to mortality for patients
at the University of Iowa Hospitals and Clinics, 1986±1991.
28-d Mortality In-hospital mortality
Organism No. of isolates (%*) (%) OR² 95% CI² P value² (%) In-hospital:28-d mortality ratio
CNS 512 (25) 17 0.63 0.48±0.82 .004 29 1.71
S. aureus 303 (15) 22 0.97 0.72±1.31 .98 31 1.40
E. coli 163 (7.9) 26 1.22 0.84±1.77 .20 35 1.38
Candida species 134 (6.5) 35 1.98 1.36±2.88 .0002 57 1.62
Klebsiella species 127 (6.2) 19 0.79 0.50±1.25 .41 37 1.96
Streptococci 113 (5.5) 18 0.73 0.44±1.19 .42 36 2.05
P. aeruginosa 104 (5.1) 31 1.58 1.02±2.43 .024 47 1.53
Enterococci 100 (4.9) 25 1.16 0.73±1.85 .34 41 1.64
Enterobacter species 98 (4.8) 27 1.26 0.79±2.01 .28 40 1.50
S. marcescens 45 (2.2) 22 0.98 0.48±2.01 .95 40 1.80
* The proportion of all isolates (n  2,046) recovered in the 1,745 episodes of bloodstream infections; only the 10 leading pathogens are listed.
² Values for increased risk of death 28 days after onset of bloodstream infection.
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Table 5. Independent predictors of 28-day mortality due to nosocomial bloodstream infection: multiple logistic regression analysis.
Variable Parameter estimate Standard error OR 95% CI P value
Age 0.0175 0.002 1.018 1.014±1.02 .0001
Length of stay 0.0092 0.003 1.009 1.003±1.02 .0020
Cancer/disease of digestive system 0.0478 0.133 1.60 1.23±2.08 .0004
Microbiological factor
Polymicrobial infection 0.5219 0.163 1.68 1.22±2.32 .0014
Pneumonia as a source 1.0068 0.193 2.74 1.87±4.00 .0001
Infection due to Candida species 0.6087 0.208 1.84 1.22±2.76 .0035
NOTE. The residual (goodness of ®t) x2 value was 2.68 with 4 degrees of freedom (P  .61). For intercept: B  02.6607; SE  0.220. In terms of relative
in¯uencing importance, the percentages of x2 uniquely associated with each independent variable in the equation predicting 28-day mortality were as follows:
age, 36%; pneumonia as a source of bloodstream infection, 23%; diagnosis of cancer or disease of the digestive tract, 11%; polymicrobial infection, 8.6%; length
of hospital stay at time of bloodstream infection, 8%; and infection due to Candida species, 7.2%.
the model, bloodstream infections due to CNS tended to predict the confounding effect of underlying disease. In fact, microbio-
logical factors profoundly in¯uence the outcome of infection:a favorable outcome and therefore relatively low mortality
(OR  0.79; 95% CI, 0.59±1.06; P  .11), and infections due independent factors in this study included pneumonia as a
source of secondary bloodstream infection, polymicrobial in-to P. aeruginosa were associated with a poor outcome (OR for
28-day mortality  1.04; 95% CI, 0.96±1.13; P  .31). fection, and Candida species as the etiologic cause. Multiple
episodes of bloodstream infection also independently affectedAll variables independently associated with 28-day mortality
due to nosocomial bloodstream infection also constituted inde- in-hospital mortality.
Earlier studies suggested that the source of bloodstream in-pendent factors in¯uencing in-hospital death. Admission to an
ICU and the occurrence of multiple episodes of bloodstream fection may predict death [2, 3, 20]. Roberts et al. [2] high-
lighted differences in mortality rates when the source ofinfection during the same hospital stay were additional inde-
pendent predictors of in-hospital death (OR  1.10; 95% CI,
1.05±1.16; P  .0001; and OR  1.15; 95% CI, 1.07±1.23;
P  .0001, respectively).
The occurrence of neutropenia either during or before the
onset of infection was associated with an increased risk of in-
hospital death (OR  1.05; 95% CI, 0.99±1.12) but did not
reach statistical signi®cance (P  .10) in the in-hospital model.
It constituted an additional independent factor in¯uencing in-
hospital mortality (OR  1.44; 95% CI, 1.06±1.96; P  .018)
when the occurrence of multiple episodes of infection was not
included in the model.
The performance of the model was evaluated with use
of receiver-operating-characteristics (ROC) curve analysis
(®gure 1). On the basis of the predicted 28-day outcome for
each patient with bloodstream infection between 1986 and 1990
(derivation set), we evaluated the sensitivity and speci®city of
the model for classifying patients who developed the infection
in 1991 (validation set) as dead or alive at 28 days. The main
reason for validation was to test the model's stability and con-
sistency. A threshold probability of 0.22 resulted in a sensitivity
of 60% and a speci®city of 67% (area under the ROC curve
Figure 1. The performance of the prognostic model was evaluatedwas 0.68).
by analysis of the receiver-operating characteristic (ROC) curve. On
the basis of the predicted 28-day outcome for each patient with noso-
comial bloodstream infection between 1986 and 1990 (n  1,439),
Discussion we evaluated the sensitivity and speci®city of the model for classifying
patients who developed the infection in 1991 (n  306) as dead or
The primary objective of the study was to evaluate the impact alive at 28 days after onset. A threshold probability of 0.22 resulted
of microbiological factors on mortality following nosocomial in a sensitivity of 60% and a speci®city of 67% (area under the ROC
curve was 0.68).bloodstream infection. Special efforts were made to adjust for
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secondary bloodstream infection was considered; pneumo- tion of blood cultures for additional organisms once one isolate
has been recovered. Whether culture bottles could be removednia, the gastrointestinal tract, and multiple sources of infec-
tion were associated with the highest mortality rates (43% ± from automated systems once they become positive without
additional, as-yet-unidenti®ed organisms being missed remains55%). These authors also suggested that the risk of death
due to bloodstream infection may extend well after 28 days to be evaluated in prospective studies.
In speci®cally designed case-control studies, estimates offollowing the onset of infection. Gatell et al. [20] showed
that bacteremia arising from intraabdominal or lower respira- the attributable mortality due to the organism causing the
infection have been given, after such confounding factorstory tract sources or from an unknown origin constituted an
independent predictor of death. have been controlled for [10, 32±36]. The attributable mortal-
ity due to bloodstream infection caused by CNS was 14%Nosocomial pneumonia is associated with a poor outcome,
particularly in mechanically ventilated patients and in the el- (95% CI, 4%±21%); by Bacteroides fragilis, 19% (95% CI,
8%±30%); by enterococci, 31% (95% CI, 22%±41%); andderly [21]. The attributable mortality of this infection was esti-
mated to be 10%, or one-third of the total crude mortality in by Candida species, 38% (95% CI, 26%±49%). Crude 28-day
mortality rates associated with those pathogens were similar ina hospital-based series [22] and 27%, or half of the total crude
mortality among mechanically ventilated patients [23]. Mortal- our study: CNS, 17%; enterococci, 25%; and Candida species,
35%. P. aeruginosa is typically associated with high mortalityity rates among patients with nosocomial pneumonia associated
with bacteremia varied between 45% and 58% in hospital-wide rates in large series [2, 20, 37], and it was suggested as an
independent predictor of death in one study [38]. Althoughseries [24±26]. In a large cohort of critically ill patients
(n 1,978) admitted to a medical ICU, Fagon and collaborators signi®cantly associated with an increased risk of death by
univariate analysis (OR  1.58 at day 28), it was not selectedrecently demonstrated that both nosocomial pneumonia
(OR  2.08) and nosocomial bacteremia (OR  2.5) indepen- as an independent predictor of 28-day or in-hospital mortality
in this study.dently contributed to death, in addition to the severity of under-
lying illness and number of dysfunctional organs [27]. We con®rmed the importance of candidal bloodstream infec-
tion. Candida species that were associated with the highestThe attributable mortality of bloodstream infection is27%,
accounting for over two-thirds of the crude mortality. We now mortality rates (35% at 28 days and 69% at discharge) in our
study cohort independently affected the outcome of infection,report that bloodstream infection arising from pneumonia is an
important predictor of mortality. Previously we reported that even after we controlled for other confounders. Given the high
mortality attributable to candidemia, single positive culturessecondary bloodstream infections were independently associ-
ated with mortality (OR  2.46) [28], but that study was small, should not be regarded, as they have been in the past, as repre-
senting benign, transient colonization [39±41].and the statistical power was inadequate to evaluate the impact
of individual species or source of infection. The dif®culty of predicting which patients will develop dis-
seminated candidiasis and the low sensitivity of blood culturesIn the present study, we found that both the 28-day mortality
(44%) and in-hospital mortality (69%) were higher than the in such conditions, coupled with the availability of systemic
antifungals with lower toxicity than amphotericin B, have ledmortality rates for bloodstream infections due to causes other
than pneumonia (table 3). This observation suggests a possible today to the consensus that all cases of candidemia should be
treated [39, 41±44]. Because the yield of blood cultures de-relationship between both the primary infection and the blood-
stream infection, as well as contributions from the underlying pends on the volume of blood cultured and because the sensitiv-
ity of low-volume blood cultures for yeast is particularly lowconditions. An entirely new study design would be required to
understand the relative contributions (to outcome) of under- [45], it is recommended that physicians order repeated, high-
volume (at least 10-mL) blood cultures for patients at high risklying disease, pneumonia, and bloodstream infection, alone or
in combination. for candidemia.
The increasing importance of CNS as nosocomial blood-Polymicrobial bateremia has been associated with higher
mortality than has unimicrobial infection in almost all series stream pathogens has recently been discussed by several au-
thors [12, 46±49]; major reasons for such an increase have been[2, 28±32]. We previously demonstrated that polymicrobial
infection was associated with poorer outcome than was uni- discussed [12, 32, 50, 51] and include surveillance artefact,
increased use of medical devices and broad-spectrum anti-microbial infection, independently of the patient's underlying
disease or the class of microorganism causing the infection biotics, and an increase in the frequency of performing blood
cultures. Recent studies have shown that the positivity of only[28]. Findings in the present study con®rm the biological con-
sistency of the phenomenon, after additional microbiological a single blood culture for CNS is frequently associated with
clinically relevant episodes of bloodstream infection [33,and other confounders were controlled for.
Appropriate antimicrobial therapy must cover all organisms 52±54]. In the study by Herwaldt and colleagues [54], 50%
of patients who met a stringent de®nition of CNS bacteremiaidenti®ed in cases of polymicrobial infection. Since those infec-
tions independently contribute to a patient's death, clinical had only one positive Isolator (DuPont Nem, Research Pro-
ducts, Boston) culture, and 28% had only one positive bloodmicrobiology laboratories should consider more careful evalua-
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culture set (BACTEC / Isolator); by multivariate analysis, meter. The odds ratios for 28-day and total in-hospital death
increased most markedly for the exposure to Candida speciesthe number of positive culture bottles was not associated with
meeting the de®nition for infection, a ®nding con®rming those (OR  1.84; 95% CI, 1.22±2.76; P  .0035; and OR  2.37;
95% CI, 1.48±3.50; P .0001, respectively) and to a primaryof other investigators [33, 52, 53].
Therefore, results of recent investigations clearly indicate infection with pneumonia (OR  2.74; 95% CI, 1.87±4.00;
P  .0001; and OR  3.38; 95% CI, 2.42±4.72; P  .0001,that the inclusion of patients in epidemiological study solely
on the basis of the number of positive cultures would not be respectively).
Only two additional factors independently in¯uenced in-appropriate. Patients with bacteremia due to CNS in our study
met prospectively de®ned criteria for infection that included hospital mortality due to bloodstream infection: occurrence of
multiple episodes of infection and admission to an ICU. Almostmore stringent criteria in cases of potential skin contaminants.
CNS are considered to be of low virulence. half (46%) of patients who suffered multiple episodes of infec-
tion had cancer. Although not statistically signi®cant, neutro-Consistent with the lower attributable mortality rate associ-
ated with bloodstream infection due to CNS [33], these infec- penia in¯uenced in-hospital outcome (OR for death  1.05;
95% CI, 0.99±1.12; P  .10); when occurrence of multipletions were associated with a signi®cantly reduced risk of death
(OR  0.63) in our study; although not statistically signi®cant episodes of infection was not considered in the model, neutro-
penia constituted an additional independent factor for in-hospi-(P  .11), exposure odds ratios for death following bacteremia
due to CNS were markedly decreased (OR  0.79; 95% CI, tal mortality (OR  1.44).
Admission to an ICU is associated with an overall increased0.54±1.06) in the multivariate model predicting 28-day mortal-
ity. The secular trends in 28-day crude mortality indicated a risk for nosocomial bloodstream infection [55]. Bloodstream
infection has been reported to be 5±7 times as likely to occurprogressive decline over the study period (P  .047); however,
after correction for the confounding effect of CNS with lower in ICU patients as in ward patients. We recently estimated the
attributable mortality associated with the infection as 35%crude mortality, the trend became nonsigni®cant (P  .47).
The consistency of data regarding the impact of microorgan- (95% CI, 25%±45%) in a cohort of surgical critically ill pa-
tients at UIHC [11]. ICU-acquired bloodstream infection sig-isms on outcome of bloodstream infection that have been ob-
tained with different methodological approaches provides addi- ni®cantly and independently affected the in-hospital outcome
in the present study population. These ®ndings are consistenttional evidence of the association between microbiological
factors and their impact on survival from such life-threatening with those of our previous report [11] and those of recent
multicenter studies [56, 57].conditions. Analytic approaches with both matched case-con-
trol studies and cohort studies employing multiple regression Re®ned outcome prediction would necessitate the inclusion of
additional clinical and biological parameters, as well as accountingtechniques to control for confounding variables have shown
the importance of different species of microorganisms or the for the dynamics of the process of sepsis [58±60]. This study was
designed to assess whether basic microbiological factors mightnature of the infection on outcome.
Our model predicted the 28-day mortality in 1991 based on independently in¯uence the outcome of infection, with use of
appropriate statistical analyses (that mandate large numbers). Ad-data gathered in 1986±1991 with 60% sensitivity and 67%
speci®city and with use of a threshold probability of 22%. It ditional variables should be included for better outcome prediction
(i.e., severity of underlying illness, additional comorbidities,is interesting that the model and its parameter estimates ob-
tained with data from the periods of 1986±1990 and shock, and multiple organ dysfunction syndrome).
Because of the limitations of our data, we do not think that1986±1991 were very similar. This observation mainly sug-
gests that our model consistently shows those factors contribut- our model can be used currently in day-to-day clinical practices
for outcome prediction. Additional microbiological factors of im-ing to the mortality but also that additional factors should be
included for further improvement. portance may include time to positive blood culture (faster detec-
tion would possibly indicate a larger inoculum), number of posi-Microbiological factors in¯uencing 28-day mortality proved
also to affect 14-day, 21-day (data not shown), and in-hospital tive culture bottles per septic episode, time between identi®cation
and therapy, and appropriateness of antimicrobial treatment.mortality independently. It is noteworthy, however, that in
terms of relative prognostic in¯uence (expressed by unique x2 Because data about those variables were not available for the
entire study cohort, we considered episodes of laboratory-provenvalues for each independent variableÐsee table 5), microbio-
logical factors explained only 38.8% of the 28-day mortality infections that lasted 72 hours or more as a reasonable surrogate
marker for those variables and tested it in the model; this para-observed. Our ®ndings need to be con®rmed in large series
from other facilities, including community hospitals. meter failed to show statistical signi®cance. However, the propor-
tion of patients who met the de®nition was relatively small (46Factors independently contributing to fatal outcome of nos-
ocomial bloodstream infection were the same when 28-day of 1,754; 2.6%); recent studies suggested that appropriate anti-
microbial therapy is the rule in most circumstances todayand in-hospital mortality models were compared (not shown).
Statistical parameters in the two models were very similar (84%±98%; see [61±63]). However, whether this could be con-
sidered as a reasonable surrogate should be further assessed.and within the con®dence intervals of each respective para-
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